BioAtla, Inc. (BCAB) Misses Q2 EPS by 6c

BioAtla, Inc. (NASDAQ: BCAB) reported Q2 EPS of ($0.32), $0.06 worse than the analyst estimate of ($0.26).

For earnings history and earnings-related data on BioAtla, Inc. (BCAB) click here.

You May Also Be Interested In

• Ditching streaming could boost Disney stock by 40%, Wells Fargo says
• Voyager tau gene therapy shows tolerability in 6-month NHP study
• Strategy sells MSTR shares worth $466.7M, made no bitcoin purchases